3. Formulation and selection criteria for beta-metastable titanium alloys

The formulation of titanium alloys is a crucial step which has been the subject of numerous studies. Starting with elements considered biocompatible (§ 1.1 ), a very wide range of compositions is offered. Electronic approaches, known as theoretical design approaches, have been proposed to select compositions without having to scan a large number of alloys. These approaches are based on electronic considerations...

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!

The Ultimate Scientific and Technical Reference

A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors

+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year

From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

This article is included in

Healthcare technologies

This offer includes:

Knowledge Base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

Practical Path

Operational and didactic, to guarantee the acquisition of transversal skills

Doc & Quiz

Interactive articles with quizzes, for constructive reading

Subscribe now!

Ongoing reading
Formulation and selection criteria for beta-metastable titanium alloys

Previous
page Evolution of alloys used

Behavior of beta-metastable titanium alloys

Bibliography

(1) - STEINEMANN (S.) - Corrosion of surgical implants-in vivo and in vitro tests, Evaluation of biomaterials. Advances in biomaterials. - John Wiley and Sons, p. 1-34 (1980).
(2) - WOLFF (J.) - The law of bone remodeling [translated from the 1892 original]...

Patents

Process for the thermomechanical treatment of a titanium alloy, alloy and prosthesis thus obtained. Inventors: LAHEURTE (P.), PRIMA (F.), GLORIANT (T.), ELMAY (W.), EBERHARDT (A.), PATOOR (E.); March 16, 2013, Patent WO 2013/068366 A1.